Bridgeworth’s Bausch Health BHC Stock Holding History

Bridgeworth’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50	Closed	-$1K	–	175
2018 Q2	$1K	Buy	+50	New	+$1.03K	﹤0.01%	582

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Bridgeworth's BHC Position: Q3 2018 in Review

Bridgeworth sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 50 shares — an estimated $1K sold.

Bridgeworth first reported a position in BHC in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

Bridgeworth reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
Bridgeworth sold 50 Bausch Health shares in Q3 2018, an estimated $1K.
Bridgeworth first reported a position in Bausch Health in Q2 2018 and held it in 1 quarter.
Bridgeworth's Bausch Health position peaked at $1K in Q2 2018.
332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.